Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Scolerly Essay Of Community Acquired Pneumonia
Scolerly Essay Of Community Acquired Pneumonia
Scolerly Essay Of Community Acquired Pneumonia
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Scolerly Essay Of Community Acquired Pneumonia
Introduction
Streptococcus pneumoniae is Gram-positive bacteria, which takes spherical shape, normally present in the form of pairs. These bacteria exist naturally in the respiratory tract, but it may become a pathogenic bacteria in the event of increased its density. These bacteria associated with different types of infections, such as pneumonia, chronic middle ear infections, meningitis, bacteremia. Pneumonia is one of the six major causes leads to death in the United States and the first reason of death from infectious diseases (Garibaldi, 1995 ; Niederman, et al 1998 cited in American Thoracic Society, 2001). Diseases caused by pneumonia was not previously diagnosed clearly, consequently, the information about its pathological effects based on simple estimates (Garibaldi, 1995 ; Niederman, et al 1998 cited in American Thoracic Society, 2001). Whitney (2000) investigate that strains of bacteria have resistance to antibiotics made treatment more complicated. The main point is pneumococci becoming more resistant to common antibiotics. Whitney (2000) mainly argued that there are dramatic increases in the proportion of pneumococci that are resistant to antibiotics and other antimicrobial agents tested. This essay will firstly summarize this article and then follow by foundation and finally will discuss the impact.
Summary
It will be summarized the article of Whitney, (2000) increasing prevalence of multidrug-resistant S. pneumoniae in the United States (Whitney et al 2000). The main point is pneumococci becoming more resistant to antibiotics. In the beginning of the 90s of the past century, the United States was experiencing a serious and worried about the emergence of S. Pneumoniae strains that have a high level of...
... middle of paper ...
...on of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455-1463.
- Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.
- Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumonia in the United States. N Engl J Med 2000;343:1917-24.
- Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730–1754.
- Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004; 38:1279–86.
Hospital-acquired infections (HAI) are preventable and pose a threat to hospitals and patients; increasing the cost, nominally and physically, for both. Pneumonia makes up approximately 15% of all HAI and is the leading cause of nosocomial deaths. Pneumonia is most frequently caused by bacterial microorganisms reaching the lungs by way of aspiration, inhalation or the hematogenous spread of a primary infection. There are two categories of Hospital-Acquired Pneumonia (HAP); Health-Care Associated Pneumonia (HCAP) and Ventilator-associated pneumonia (VAP).
However, increasing antibiotic resistance patterns among intensive care unit pathogens, cultivated by empiric-broad spectrum antibiotic regimens, characterizes the variable concerns. Recent literature point that antibiotic use before the development of VAP is associated with increased risk for potentially resistant gran-negative infections and Methcillin-resistant Staphylococcus auereus (MRSA)
Yang, J. (2009, August 21). Experts concerned about dangers of antibacterial products. The Globe and
Concerning the morbidity rate of Streptococcal pneumonia I have learned that as a cumulative total, this disease was more prominent in 2012 but not by much. I also learned that the incident values for this disease were all over the place, up and down, but in the end both 2012 and 2013 ended up with the same amount right on the dot.
The article’s information is presented with the goal of informing a reader on vaccines. The evidence is statistical and unbiased, showing data on both side effects and disease prevention, providing rates of death and serious illness from both sides. This evidence is sourced from a variety of medical organizations and seems reliable, logical, and easily understood, no language that would inspire an emotional response is used. The validity of studies is not mentioned in the article, but it does encourage readers to investigate further to help make a decision. The article allows a reader to analyze the presented evidence and come to their own
Group A streptococcus bacteria can be treated with common, inexpensive antibiotics. Penicillin is the drug of choice for both mild and severe disease. In addition to antibiotics, supportive care in an intensive care unit and sometimes surgery are necessary with these diseases. Early treatment may reduce the risk of death although, unfortunately, even appropriate therapy does not prevent death in every case. The spread of all types of group A streptococcal infections may be reduced by good hand washing, especially after coughing and sneezing, before and after preparing foods and before eating.
Another campaign developed by the CDC is the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR). This task force focused on urgent antimicrobial resistance issues and appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities. Also, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs()
Throughout history disease has run rampant taking many lives with every passing day. Finding a cure or even just a tool in the battle has been the main focus of scientist throughout time. This focus is what brought us the discovery of antibiotics. Over the years antibiotics have been misused by patients, over prescribed by physicians and have led to resistant strains of bacteria.
Swiatlo, E., & Ware, D. (2003). Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunology and Medical Microbiology, 38(1), 1-7. Retrieved from http://www.sciencedirect.com/science/article/pii/S0928824403001469 (Accessed December 11, 2013).
Bacterial resistance to antibiotics has presented many problems in our society, including an increased chance of fatality due to infections that could have otherwise been treated with success. Antibiotics are used to treat bacterial infections, but overexposure to these drugs give the bacteria more opportunities to mutate, forming resistant strains. Through natural selection, those few mutated bacteria are able to survive treatments of antibiotics and then pass on their genes to other bacterial cells through lateral gene transfer (Zhaxybayeva, 2011). Once resistance builds in one patient, it is possible for the strain to be transmitted to others through improper hygiene and failure to isolate patients in hospitals.
S. pyogenes is a bacterium that permeates our society. Today it is commonly known as the cause of “Strep. throat,” or Streptococcal pharyngitis. Modern medicine has caused the eradication of most of its advanced infections, while this most common form of infection still thrives. It is very contagious, and pyogenes travels quickly through places where bacteria flourish, such as schools and health institutions. The body cannot fight this bacterium very well without help, and S. pyogenes was a common cause of death until the introduction of antibiotics in the twentieth century. It has a number of ways to subdue the immune system, but it is almost completely vulnerable to penicillin, even after decades of exposure. While generally no more than a nuisance, this bacterium continues to be an interesting topic of discussion. (6,3,2)
Bibliography:.. References 1) Lewis, Ricki, “The Rise of Antibiotic-Resistant Infections”. Food and Drug Administration Publications. http://www.fda.gov/fdac/features/795_antibio.html September, 1995. 2) Levy, S., Bittner, M., and Salyers, A. Ask the Experts about “Ask the Experts”.
There are many medical professionals who believe that the rise of antibiotic resistance is a result of the overuse and misuse of antibiotics. Dr. Jim Wilde, a paediatric emergency medicine physician at the Medical College of Georgia believes that the medical profession is losing the war against resistance...
What if there were no treatment for strep throat? Or pneumonia? Or sinus infections? It is hard to imagine life without medicine for these illnesses. But what if the antibiotics used to treat bacterial infections such as strep throat and pneumonia stopped working? What if the bacteria were stronger than the antibiotics? The threat of antibiotic-resistant bacterial infections is an increasing concern for healthcare providers, and it is important to reduce the misuse and overuse of antibiotics to maintain control of bacterial diseases.
This enables a significant percentage of individuals who oppose vaccines to reconcile with those who do not, as this eliminates the concern regarding adverse reactions. According to an article titled “Vaccine herd effect,” herd immunity has pervaded many communities to help minimize the spread of disease. For example, in the 1990s, a vaccine was introduced that targeted a strain of disease known as streptococcus pneumoniae, which can potentially cause pneumonia. The CDC discovered a fifty percent reduction in pneumonia cases among the elderly despite the vaccine being offered primarily to children (Kim, T. H., Johnstone, J., & Loeb, M., 2011).